BridgeBio Pharma, Inc. (BBIO) has 113 open-market insider trades by 27 insiders since 2019. The most active filer is Neil Kumar, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Henry R. Kravis | 10% Owner | — | 1 | $410.4M | 2025-05-12 |
| KKR Genetic Disorder L.P. | 10% Owner | — | 2 | $368.2M | 2021-02-17 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | — | 1 | $214.0M | 2025-01-31 |
| KKR Group Holdings Corp. | 10% Owner | — | 1 | $197.8M | 2025-03-05 |
| KKR & Co. Inc. | 10% Owner | — | 2 | $194.4M | 2024-09-13 |
| Ole Andreas Halvorsen | 10% Owner | — | 1 | $154.0M | 2025-06-27 |
| Rose Sharon Shabet | 10% Owner | — | 1 | $80.0M | 2019-06-27 |
| Viking Global Opportunities GP LLC | 10% Owner | — | 1 | $52.5M | 2023-07-18 |
| Neil Kumar | CEO | — | 19 | $44.4M | 2026-09-17 |
| Frank McCormick | Dir | — | 5 | $23.8M | 2026-06-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Neil Kumar | CEO | Sell | $691K | 2026-09-17 |
| Neil Kumar | CEO | Sell | $3.7M | 2026-08-18 |
| Maricel Apuli | CAO | Sell | $160K | 2026-07-30 |
| Andrea Ellis | Director | Sell | $1.4M | 2026-07-09 |
| Jennifer E. Cook | Director | Sell | $13.2M | 2026-07-09 |
| Jennifer E. Cook | Director | Sell | $2.8M | 2026-06-23 |
Companies that share insiders with BBIO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Hannah Valantine | Director | Sell | $342K | 2026-06-22 |
| Jennifer E. Cook | Director | Sell | $6.0M | 2026-06-15 |
| Neil Kumar | CEO | Sell | $4.6M | 2026-06-04 |
| Neil Kumar | CEO | Sell | $1.8M | 2026-05-21 |
| Thomas Trimarchi | President & CFO | Sell | $888K | 2026-05-18 |
| Randal W. Scott | Director | Sell | $671K | 2026-05-15 |
| Neil Kumar | CEO | Sell | $5.3M | 2026-05-07 |
| Maricel Apuli | CAO | Sell | $143K | 2026-04-30 |
| Neil Kumar | CEO | Sell | $6.0M | 2026-04-09 |